SOLAVAX

Serial Number 88846226
Registration 6890077
700

Registration Progress

Application Filed
Mar 24, 2020
Under Examination
Sep 15, 2020
Approved for Publication
Jul 21, 2020
Published for Opposition
Jul 21, 2020
Registered
Nov 1, 2022

Trademark Image

SOLAVAX

Basic Information

Serial Number
88846226
Registration Number
6890077
Filing Date
March 24, 2020
Registration Date
November 1, 2022
Published for Opposition
July 21, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 1, 2022
Registration
Registered
Classes
005

Rights Holder

Colorado State University Research Foundation

03
Address
2537 Research Blvd., Suite 200
Fort Collins, CO 80526

Ownership History

Colorado State University Research Foundation

Original Applicant
03
Fort Collins, CO

Colorado State University Research Foundation

Owner at Publication
03
Fort Collins, CO

Colorado State University Research Foundation

Original Registrant
03
Fort Collins, CO

Legal Representation

Attorney
Sabrina C. Stavish

USPTO Deadlines

Next Deadline
1189 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-11-01)
Due Date
November 01, 2028
Grace Period Ends
May 01, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

28 events
Date Code Type Description Documents
Nov 1, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 1, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 27, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Sep 26, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Sep 23, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Sep 23, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 12, 2022 IUAF S USE AMENDMENT FILED Loading...
Sep 12, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Mar 3, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 1, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 1, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Mar 1, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 2, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 31, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 31, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 31, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 13, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 11, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 11, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 11, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 15, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 21, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 21, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 1, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 15, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 15, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 29, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 27, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
vaccines
First Use Anywhere: Sep 8, 2022
First Use in Commerce: Sep 8, 2022

Classification

International Classes
005